A recent CBS News investigation highlights the continued sale of unapproved retatrutide products through convenience stores and other unauthorized channels. The report underscores growing concerns surrounding product quality, consumer safety, and the importance of sourcing peptide products through legitimate, compliant pathways. As interest in next-generation metabolic therapies grows, strengthening education and industry standards remains essential to protecting patients and preserving confidence in peptide science.
Read the Full Article
https://www.cbsnews.com/news/weight-loss-drug-retatrutide-unapproved-sales-convenience-store/